scholarly journals Management of Unfavorable Intermediate and High Risk Prostate Cancer with Stereotactic Body Radiation Therapy as Monotherapy Versus Boost: A Ten Year Study

2018 ◽  
Vol 102 (3) ◽  
pp. e121-e122
Author(s):  
A. Katz ◽  
J. Kang
Sign in / Sign up

Export Citation Format

Share Document